Steven Cohen's CVS Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 426,087 shares of CVS Health Corporation (CVS) worth $32.12 M, representing 0.05% of the portfolio. First purchased in 2014-Q3, this long-term strategic position has been held for 32 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in CVS, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2017, adding 1.36 M shares. Largest reduction occurred in Q1 2019, reducing 954,250 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's CVS Health Corporation (CVS) Holding Value Over Time
Track share changes against reported price movement
Quarterly CVS Health Corporation (CVS) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2014 | +60,300 | New Buy | 60,300 | $79.59 |
| Q4 2014 | -60,300 | Sold Out | 0 | $0.00 |
| Q2 2015 | +34,300 | New Buy | 34,300 | $104.87 |
| Q3 2015 | -34,300 | Sold Out | 0 | $0.00 |
| Q1 2016 | +115,300 | New Buy | 115,300 | $103.73 |
| Q2 2016 | -115,300 | Sold Out | 0 | $0.00 |
| Q3 2016 | +82,162 | New Buy | 82,162 | $88.99 |
| Q4 2016 | +30,738 | Add 37.41% | 112,900 | $78.91 |
| Q1 2017 | +97,712 | Add 86.55% | 210,612 | $78.50 |
| Q2 2017 | -18,412 | Reduce 8.74% | 192,200 | $80.46 |
| Q3 2017 | -157,200 | Reduce 81.79% | 35,000 | $81.31 |
| Q4 2017 | +1.36 M | Add 3874.25% | 1.39 M | $72.50 |
| Q1 2018 | -576,489 | Reduce 41.44% | 814,500 | $62.21 |
| Q2 2018 | +7,500 | Add 0.92% | 822,000 | $64.35 |
| Q3 2018 | +1.13 M | Add 137.71% | 1.95 M | $78.72 |
| Q4 2018 | -850,515 | Reduce 43.53% | 1.1 M | $65.52 |
| Q1 2019 | -954,250 | Reduce 86.48% | 149,192 | $53.93 |
| Q2 2019 | -149,192 | Sold Out | 0 | $0.00 |
| Q3 2019 | +360,526 | New Buy | 360,526 | $63.07 |
| Q4 2019 | -360,526 | Sold Out | 0 | $0.00 |
| Q4 2020 | +215,000 | New Buy | 215,000 | $68.30 |
| Q1 2021 | -215,000 | Sold Out | 0 | $0.00 |
| Q4 2022 | +1,962 | New Buy | 1,962 | $93.19 |
| Q1 2023 | +14,356 | Add 731.70% | 16,318 | $74.31 |
| Q2 2023 | -15,825 | Reduce 96.98% | 493 | $69.13 |
| Q3 2023 | +4,054 | Add 822.31% | 4,547 | $69.82 |
| Q4 2023 | +552,509 | Add 12151.07% | 557,056 | $78.96 |
| Q1 2024 | -557,056 | Sold Out | 0 | $0.00 |
| Q3 2024 | +398,816 | New Buy | 398,816 | $62.88 |
| Q4 2024 | +32,894 | Add 8.25% | 431,710 | $44.89 |
| Q1 2025 | -431,710 | Sold Out | 0 | $0.00 |
| Q3 2025 | +426,087 | New Buy | 426,087 | $75.39 |
Steven Cohen's CVS Health Corporation Investment FAQs
Steven Cohen first purchased CVS Health Corporation (CVS) in Q3 2014, acquiring 60,300 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held CVS Health Corporation (CVS) for 32 quarters since Q3 2014.
Steven Cohen's largest addition to CVS Health Corporation (CVS) was in Q4 2017, adding 1,390,989 shares worth $100.85 M.
According to the latest 13F filing for Q3 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 426,087 shares of CVS Health Corporation (CVS), valued at approximately $32.12 M.
As of the Q3 2025 filing, CVS Health Corporation (CVS) represents approximately 0.05% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in CVS Health Corporation (CVS) was 1,953,957 shares, as reported at the end of Q3 2018.